Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Silymarin | 18 | 2014 | 40 | 2.500 |
Why?
|
Grape Seed Extract | 9 | 2019 | 12 | 1.470 |
Why?
|
Antineoplastic Agents, Phytogenic | 12 | 2019 | 623 | 1.310 |
Why?
|
Anticarcinogenic Agents | 5 | 2016 | 253 | 0.990 |
Why?
|
Phytic Acid | 4 | 2012 | 23 | 0.950 |
Why?
|
Prostatic Neoplasms | 23 | 2022 | 11059 | 0.950 |
Why?
|
Momordica charantia | 3 | 2020 | 10 | 0.930 |
Why?
|
Adenocarcinoma | 12 | 2022 | 6363 | 0.910 |
Why?
|
Plant Extracts | 6 | 2020 | 471 | 0.890 |
Why?
|
Apoptosis | 21 | 2020 | 9718 | 0.550 |
Why?
|
Cell Nucleus | 1 | 2022 | 2969 | 0.460 |
Why?
|
Colorectal Neoplasms | 9 | 2014 | 6773 | 0.450 |
Why?
|
Seeds | 3 | 2013 | 105 | 0.430 |
Why?
|
Herpesvirus 8, Human | 2 | 2024 | 258 | 0.410 |
Why?
|
Autophagy | 3 | 2016 | 1296 | 0.390 |
Why?
|
Chromatin | 1 | 2022 | 2931 | 0.380 |
Why?
|
Sarcoma, Kaposi | 2 | 2024 | 370 | 0.380 |
Why?
|
Azoxymethane | 3 | 2022 | 36 | 0.360 |
Why?
|
Phytotherapy | 2 | 2012 | 298 | 0.350 |
Why?
|
Vitis | 2 | 2013 | 18 | 0.330 |
Why?
|
Neovascularization, Pathologic | 6 | 2018 | 2638 | 0.330 |
Why?
|
NF-kappa B | 6 | 2013 | 2500 | 0.330 |
Why?
|
Gallic Acid | 1 | 2008 | 24 | 0.330 |
Why?
|
Neoplastic Stem Cells | 4 | 2019 | 1376 | 0.320 |
Why?
|
Cell Proliferation | 19 | 2020 | 10477 | 0.320 |
Why?
|
Antioxidants | 5 | 2014 | 1658 | 0.320 |
Why?
|
Cytotoxins | 1 | 2007 | 153 | 0.290 |
Why?
|
Anthocyanins | 2 | 2019 | 79 | 0.280 |
Why?
|
Antineoplastic Agents | 8 | 2018 | 13691 | 0.280 |
Why?
|
Mice | 29 | 2022 | 81154 | 0.260 |
Why?
|
Prostate | 6 | 2022 | 1763 | 0.260 |
Why?
|
Mice, Transgenic | 9 | 2013 | 9731 | 0.260 |
Why?
|
Disease Models, Animal | 8 | 2022 | 18027 | 0.260 |
Why?
|
Cell Line, Tumor | 19 | 2018 | 16674 | 0.250 |
Why?
|
Animals | 38 | 2022 | 168660 | 0.250 |
Why?
|
Drug Screening Assays, Antitumor | 4 | 2016 | 729 | 0.250 |
Why?
|
Gonadotropin-Releasing Hormone | 3 | 2004 | 1205 | 0.240 |
Why?
|
Oxidative Stress | 3 | 2013 | 3082 | 0.230 |
Why?
|
Mice, Nude | 8 | 2020 | 3680 | 0.220 |
Why?
|
Urinary Bladder Neoplasms | 2 | 2013 | 2248 | 0.220 |
Why?
|
Energy Metabolism | 2 | 2014 | 2899 | 0.210 |
Why?
|
Xenograft Model Antitumor Assays | 8 | 2020 | 3547 | 0.210 |
Why?
|
Dextran Sulfate | 1 | 2022 | 236 | 0.200 |
Why?
|
Reactive Oxygen Species | 3 | 2013 | 2077 | 0.190 |
Why?
|
Mustard Gas | 1 | 2020 | 16 | 0.190 |
Why?
|
Chemical Warfare Agents | 1 | 2020 | 21 | 0.190 |
Why?
|
Cell Cycle | 3 | 2018 | 2963 | 0.190 |
Why?
|
Disease Progression | 9 | 2017 | 13273 | 0.190 |
Why?
|
Cell Transformation, Neoplastic | 3 | 2022 | 2942 | 0.180 |
Why?
|
Pancreatic Neoplasms | 4 | 2020 | 5264 | 0.180 |
Why?
|
Mice, Inbred C57BL | 7 | 2022 | 21824 | 0.180 |
Why?
|
Biflavonoids | 1 | 2019 | 11 | 0.170 |
Why?
|
Proanthocyanidins | 1 | 2019 | 20 | 0.170 |
Why?
|
AMP-Activated Protein Kinases | 2 | 2013 | 610 | 0.170 |
Why?
|
Indoles | 2 | 2018 | 1841 | 0.170 |
Why?
|
Cation Transport Proteins | 1 | 2022 | 327 | 0.170 |
Why?
|
Metabolomics | 3 | 2013 | 1487 | 0.170 |
Why?
|
Rad52 DNA Repair and Recombination Protein | 1 | 2018 | 32 | 0.170 |
Why?
|
Catechin | 1 | 2019 | 66 | 0.170 |
Why?
|
Cell Survival | 8 | 2019 | 5881 | 0.160 |
Why?
|
HT29 Cells | 3 | 2014 | 200 | 0.160 |
Why?
|
RNA Splicing | 1 | 2022 | 907 | 0.150 |
Why?
|
Nitric Oxide Synthase Type II | 2 | 2010 | 534 | 0.150 |
Why?
|
Flavones | 1 | 2017 | 66 | 0.150 |
Why?
|
Administration, Oral | 3 | 2011 | 3912 | 0.150 |
Why?
|
Mammals | 1 | 2022 | 1143 | 0.150 |
Why?
|
Spheroids, Cellular | 2 | 2019 | 348 | 0.140 |
Why?
|
Carcinoma, Basal Cell | 1 | 2022 | 545 | 0.140 |
Why?
|
Serine Endopeptidases | 1 | 2022 | 1073 | 0.140 |
Why?
|
Neoplasms | 4 | 2016 | 21675 | 0.140 |
Why?
|
Caspase 3 | 4 | 2013 | 758 | 0.140 |
Why?
|
Deoxycytidine | 1 | 2020 | 826 | 0.140 |
Why?
|
Immunohistochemistry | 7 | 2013 | 11360 | 0.130 |
Why?
|
Recombinant Proteins | 2 | 2004 | 6620 | 0.130 |
Why?
|
Peptides | 2 | 2004 | 4406 | 0.130 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 2 | 2013 | 365 | 0.130 |
Why?
|
Drug Resistance | 1 | 2020 | 1606 | 0.120 |
Why?
|
Cadherins | 3 | 2018 | 907 | 0.120 |
Why?
|
Proto-Oncogene Proteins c-akt | 3 | 2013 | 2504 | 0.120 |
Why?
|
Colon | 1 | 2022 | 1772 | 0.120 |
Why?
|
STAT3 Transcription Factor | 3 | 2013 | 873 | 0.120 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2022 | 1581 | 0.120 |
Why?
|
Blotting, Western | 6 | 2013 | 5179 | 0.120 |
Why?
|
BRCA2 Protein | 1 | 2018 | 794 | 0.120 |
Why?
|
Signal Transduction | 10 | 2018 | 23398 | 0.120 |
Why?
|
Male | 33 | 2022 | 349776 | 0.120 |
Why?
|
Momordica | 1 | 2013 | 1 | 0.120 |
Why?
|
RNA-Binding Proteins | 1 | 2022 | 1900 | 0.110 |
Why?
|
Colonic Neoplasms | 3 | 2014 | 2542 | 0.110 |
Why?
|
Interleukin-4 | 2 | 2014 | 1147 | 0.110 |
Why?
|
Comfrey | 1 | 2012 | 1 | 0.110 |
Why?
|
Receptors, TNF-Related Apoptosis-Inducing Ligand | 1 | 2012 | 59 | 0.110 |
Why?
|
Glyceric Acids | 1 | 2012 | 17 | 0.110 |
Why?
|
Hydroxamic Acids | 2 | 2013 | 494 | 0.110 |
Why?
|
Mitogens | 1 | 2013 | 232 | 0.110 |
Why?
|
Flavonolignans | 1 | 2012 | 1 | 0.110 |
Why?
|
Epidermal Growth Factor | 2 | 2013 | 709 | 0.110 |
Why?
|
Somatomedins | 1 | 2013 | 192 | 0.110 |
Why?
|
Biological Assay | 1 | 2016 | 650 | 0.110 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2017 | 11524 | 0.110 |
Why?
|
Glucose Transporter Type 4 | 1 | 2012 | 250 | 0.110 |
Why?
|
Vacuoles | 1 | 2013 | 229 | 0.100 |
Why?
|
Superoxides | 1 | 2013 | 387 | 0.100 |
Why?
|
Lung Neoplasms | 6 | 2014 | 13112 | 0.100 |
Why?
|
Plant Preparations | 1 | 2012 | 94 | 0.100 |
Why?
|
Macrolides | 1 | 2013 | 201 | 0.100 |
Why?
|
Growth Inhibitors | 1 | 2013 | 385 | 0.100 |
Why?
|
Cell Shape | 1 | 2013 | 375 | 0.100 |
Why?
|
Cell Movement | 3 | 2019 | 5216 | 0.100 |
Why?
|
MicroRNAs | 2 | 2020 | 3750 | 0.100 |
Why?
|
Virus Latency | 2 | 2024 | 358 | 0.100 |
Why?
|
Humans | 43 | 2024 | 743811 | 0.100 |
Why?
|
Tumor Cells, Cultured | 3 | 2020 | 6311 | 0.100 |
Why?
|
Body Weight | 3 | 2012 | 4670 | 0.100 |
Why?
|
Cell Death | 2 | 2013 | 1705 | 0.090 |
Why?
|
Histone Deacetylase Inhibitors | 2 | 2013 | 789 | 0.090 |
Why?
|
Immunoblotting | 3 | 2010 | 1683 | 0.090 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2014 | 10940 | 0.090 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 2 | 2009 | 480 | 0.090 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 2 | 2009 | 489 | 0.090 |
Why?
|
Proliferating Cell Nuclear Antigen | 2 | 2008 | 286 | 0.090 |
Why?
|
Enzyme Activation | 2 | 2013 | 3701 | 0.090 |
Why?
|
Diet | 2 | 2022 | 7930 | 0.090 |
Why?
|
T-Lymphocytes | 2 | 2004 | 10179 | 0.090 |
Why?
|
Carcinogens | 2 | 2013 | 466 | 0.090 |
Why?
|
Phosphorylation | 6 | 2013 | 8436 | 0.090 |
Why?
|
In Situ Nick-End Labeling | 2 | 2009 | 644 | 0.090 |
Why?
|
Immunoenzyme Techniques | 2 | 2013 | 1799 | 0.090 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2020 | 1637 | 0.090 |
Why?
|
Dietary Fiber | 1 | 2013 | 759 | 0.080 |
Why?
|
Citrates | 1 | 2009 | 131 | 0.080 |
Why?
|
Nuclear Proteins | 1 | 2024 | 5854 | 0.080 |
Why?
|
Cytoplasm | 1 | 2013 | 1536 | 0.080 |
Why?
|
Butylhydroxybutylnitrosamine | 1 | 2007 | 2 | 0.080 |
Why?
|
Prostatic Intraepithelial Neoplasia | 1 | 2008 | 75 | 0.080 |
Why?
|
Inositol | 1 | 2009 | 218 | 0.080 |
Why?
|
Drug Resistance, Neoplasm | 2 | 2020 | 5170 | 0.080 |
Why?
|
Microtubule-Associated Proteins | 1 | 2013 | 1083 | 0.080 |
Why?
|
Macrophages, Alveolar | 1 | 2010 | 407 | 0.080 |
Why?
|
Adipocytes | 1 | 2014 | 1182 | 0.080 |
Why?
|
Adenine | 1 | 2013 | 935 | 0.080 |
Why?
|
Choline | 1 | 2009 | 492 | 0.070 |
Why?
|
Receptors, Androgen | 1 | 2013 | 1055 | 0.070 |
Why?
|
Mice, Inbred Strains | 3 | 2017 | 1826 | 0.070 |
Why?
|
Models, Biological | 2 | 2014 | 9582 | 0.070 |
Why?
|
Cell Polarity | 1 | 2010 | 645 | 0.070 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 5 | 2017 | 5230 | 0.070 |
Why?
|
Inclusion Bodies | 2 | 2004 | 279 | 0.070 |
Why?
|
Nuclear Magnetic Resonance, Biomolecular | 1 | 2009 | 506 | 0.070 |
Why?
|
Principal Component Analysis | 1 | 2009 | 935 | 0.070 |
Why?
|
Protein Transport | 1 | 2011 | 1988 | 0.070 |
Why?
|
Protein Kinases | 1 | 2013 | 1640 | 0.070 |
Why?
|
Vascular Endothelial Growth Factor A | 4 | 2009 | 3510 | 0.070 |
Why?
|
Magnetic Resonance Imaging | 1 | 2012 | 35409 | 0.070 |
Why?
|
Protein Biosynthesis | 1 | 2013 | 2123 | 0.070 |
Why?
|
Hedgehog Proteins | 2 | 2022 | 784 | 0.060 |
Why?
|
Neoplasm Invasiveness | 3 | 2020 | 3617 | 0.060 |
Why?
|
Epigenesis, Genetic | 3 | 2013 | 3645 | 0.060 |
Why?
|
Enzyme Inhibitors | 2 | 2013 | 3794 | 0.060 |
Why?
|
Cyclins | 1 | 2007 | 603 | 0.060 |
Why?
|
Interleukin-6 | 1 | 2014 | 3208 | 0.060 |
Why?
|
Down-Regulation | 4 | 2014 | 3000 | 0.060 |
Why?
|
Inflammation | 2 | 2022 | 10629 | 0.060 |
Why?
|
Protein Subunits | 2 | 2004 | 959 | 0.060 |
Why?
|
Escherichia coli | 3 | 2004 | 4216 | 0.060 |
Why?
|
Cyclin-Dependent Kinases | 1 | 2007 | 671 | 0.060 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2013 | 2110 | 0.060 |
Why?
|
Species Specificity | 1 | 2007 | 2480 | 0.060 |
Why?
|
Chemoprevention | 2 | 2018 | 319 | 0.060 |
Why?
|
Skin Neoplasms | 1 | 2022 | 5691 | 0.050 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 4 | 2013 | 3874 | 0.050 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2012 | 3758 | 0.050 |
Why?
|
Angiogenesis Inhibitors | 2 | 2009 | 2037 | 0.050 |
Why?
|
Gene Expression Regulation, Viral | 1 | 2024 | 442 | 0.050 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2011 | 2281 | 0.050 |
Why?
|
Neoplasm Proteins | 1 | 2014 | 3706 | 0.050 |
Why?
|
Dietary Supplements | 1 | 2014 | 3292 | 0.050 |
Why?
|
Protein Folding | 1 | 2004 | 840 | 0.050 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2004 | 1574 | 0.050 |
Why?
|
Monocytes | 1 | 2010 | 2593 | 0.050 |
Why?
|
Lipid Metabolism | 1 | 2009 | 1885 | 0.050 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2011 | 4422 | 0.040 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2009 | 2938 | 0.040 |
Why?
|
Gene Expression Regulation, Neoplastic | 4 | 2018 | 8430 | 0.040 |
Why?
|
Mitochondria | 1 | 2012 | 3513 | 0.040 |
Why?
|
Antigens, Viral | 1 | 2024 | 1035 | 0.040 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2004 | 2556 | 0.040 |
Why?
|
Poly(ADP-ribose) Polymerases | 2 | 2013 | 437 | 0.040 |
Why?
|
Drug Synergism | 2 | 2013 | 1794 | 0.040 |
Why?
|
Lung | 2 | 2014 | 9858 | 0.040 |
Why?
|
Zinc | 1 | 2022 | 683 | 0.040 |
Why?
|
Flavonols | 1 | 2017 | 83 | 0.040 |
Why?
|
Respiratory System | 1 | 2020 | 557 | 0.040 |
Why?
|
Ultraviolet Rays | 1 | 2022 | 1060 | 0.040 |
Why?
|
Cancer Vaccines | 1 | 2004 | 1023 | 0.040 |
Why?
|
Glucose | 1 | 2009 | 4398 | 0.040 |
Why?
|
Cell Cycle Proteins | 1 | 2008 | 3463 | 0.040 |
Why?
|
Cyclin D1 | 2 | 2009 | 463 | 0.040 |
Why?
|
Antimetabolites, Antineoplastic | 1 | 2020 | 640 | 0.040 |
Why?
|
Mitogen-Activated Protein Kinases | 2 | 2013 | 1284 | 0.030 |
Why?
|
Insulin-Like Growth Factor I | 2 | 2018 | 2017 | 0.030 |
Why?
|
Kinetics | 2 | 2014 | 6476 | 0.030 |
Why?
|
Female | 7 | 2022 | 380020 | 0.030 |
Why?
|
Receptor, Notch1 | 1 | 2019 | 502 | 0.030 |
Why?
|
Virus Replication | 1 | 2024 | 2535 | 0.030 |
Why?
|
Recombinant Fusion Proteins | 1 | 2004 | 3772 | 0.030 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2018 | 2944 | 0.030 |
Why?
|
DNA Repair | 1 | 2024 | 2045 | 0.030 |
Why?
|
Flavonoids | 1 | 2017 | 443 | 0.030 |
Why?
|
DNA, Neoplasm | 2 | 2010 | 1758 | 0.030 |
Why?
|
Models, Animal | 1 | 2020 | 2172 | 0.030 |
Why?
|
Neoplasm Staging | 1 | 2008 | 11036 | 0.030 |
Why?
|
Peptide Mapping | 1 | 2014 | 263 | 0.030 |
Why?
|
Wnt Proteins | 1 | 2018 | 721 | 0.030 |
Why?
|
HCT116 Cells | 1 | 2014 | 409 | 0.030 |
Why?
|
Mice, Inbred A | 1 | 2013 | 248 | 0.030 |
Why?
|
Receptors, Notch | 1 | 2018 | 739 | 0.030 |
Why?
|
Phosphatidylinositol 3-Kinase | 1 | 2014 | 130 | 0.030 |
Why?
|
Cyclin B1 | 1 | 2012 | 52 | 0.030 |
Why?
|
bcl-2 Homologous Antagonist-Killer Protein | 1 | 2013 | 75 | 0.030 |
Why?
|
Caspase 9 | 1 | 2013 | 188 | 0.030 |
Why?
|
Liver Neoplasms | 1 | 2008 | 4251 | 0.030 |
Why?
|
Cell Line | 2 | 2020 | 15993 | 0.030 |
Why?
|
Cytochromes c | 1 | 2013 | 180 | 0.030 |
Why?
|
Animals, Genetically Modified | 1 | 2017 | 1552 | 0.030 |
Why?
|
Protein Stability | 1 | 2014 | 556 | 0.030 |
Why?
|
DNA Replication | 1 | 2018 | 1399 | 0.030 |
Why?
|
Membrane Potential, Mitochondrial | 1 | 2012 | 298 | 0.030 |
Why?
|
Kidney Neoplasms | 1 | 2008 | 4260 | 0.020 |
Why?
|
Methionine | 1 | 2014 | 590 | 0.020 |
Why?
|
Urethane | 1 | 2010 | 40 | 0.020 |
Why?
|
Azacitidine | 1 | 2013 | 347 | 0.020 |
Why?
|
Androgens | 1 | 2018 | 1247 | 0.020 |
Why?
|
Doxorubicin | 1 | 2017 | 2234 | 0.020 |
Why?
|
Gene Expression | 1 | 2024 | 7793 | 0.020 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2013 | 623 | 0.020 |
Why?
|
Genes, p53 | 1 | 2012 | 755 | 0.020 |
Why?
|
Transforming Growth Factor beta | 1 | 2018 | 2006 | 0.020 |
Why?
|
Intermediate Filament Proteins | 1 | 2010 | 269 | 0.020 |
Why?
|
DNA | 1 | 2024 | 7295 | 0.020 |
Why?
|
Cytosol | 1 | 2013 | 901 | 0.020 |
Why?
|
Acetylation | 1 | 2012 | 1084 | 0.020 |
Why?
|
Caspases | 1 | 2012 | 928 | 0.020 |
Why?
|
Phenols | 1 | 2013 | 496 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-jun | 1 | 2010 | 286 | 0.020 |
Why?
|
Cell Growth Processes | 1 | 2009 | 399 | 0.020 |
Why?
|
DNA Damage | 1 | 2018 | 2429 | 0.020 |
Why?
|
Vitamin E | 1 | 2013 | 868 | 0.020 |
Why?
|
X-Ray Microtomography | 1 | 2010 | 428 | 0.020 |
Why?
|
Carrier Proteins | 1 | 2022 | 5021 | 0.020 |
Why?
|
Microscopy, Confocal | 1 | 2014 | 1962 | 0.020 |
Why?
|
Transcription Factor AP-1 | 1 | 2010 | 317 | 0.020 |
Why?
|
Oxidation-Reduction | 1 | 2014 | 2183 | 0.020 |
Why?
|
Vimentin | 1 | 2008 | 262 | 0.020 |
Why?
|
Bronchoalveolar Lavage Fluid | 1 | 2010 | 768 | 0.020 |
Why?
|
Vascular Endothelial Growth Factor Receptor-2 | 1 | 2010 | 547 | 0.020 |
Why?
|
beta Catenin | 1 | 2013 | 1060 | 0.020 |
Why?
|
Antibodies, Monoclonal | 1 | 2004 | 9272 | 0.020 |
Why?
|
Mice, Inbred ICR | 1 | 2007 | 352 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-fos | 1 | 2010 | 575 | 0.020 |
Why?
|
Skin | 1 | 2020 | 4372 | 0.020 |
Why?
|
Nitric Oxide Synthase Type III | 1 | 2009 | 689 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2014 | 4749 | 0.020 |
Why?
|
Gene Silencing | 1 | 2013 | 1537 | 0.020 |
Why?
|
Matrix Metalloproteinases | 1 | 2008 | 391 | 0.020 |
Why?
|
Cytokines | 2 | 2013 | 7324 | 0.020 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2009 | 627 | 0.020 |
Why?
|
Protein Processing, Post-Translational | 1 | 2014 | 1986 | 0.020 |
Why?
|
MAP Kinase Signaling System | 1 | 2013 | 1524 | 0.020 |
Why?
|
Seminiferous Tubules | 1 | 2004 | 25 | 0.020 |
Why?
|
Tumor Burden | 1 | 2010 | 1917 | 0.020 |
Why?
|
Neoplasm Transplantation | 1 | 2009 | 2085 | 0.020 |
Why?
|
Microvessels | 1 | 2009 | 544 | 0.020 |
Why?
|
Genes, Synthetic | 1 | 2004 | 90 | 0.020 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2013 | 3917 | 0.020 |
Why?
|
Microcirculation | 1 | 2008 | 1287 | 0.010 |
Why?
|
Mice, Inbred BALB C | 1 | 2013 | 6380 | 0.010 |
Why?
|
Transcription Factors | 2 | 2014 | 12209 | 0.010 |
Why?
|
Up-Regulation | 1 | 2013 | 4221 | 0.010 |
Why?
|
Homeodomain Proteins | 1 | 2013 | 2419 | 0.010 |
Why?
|
Gene Deletion | 1 | 2010 | 2749 | 0.010 |
Why?
|
Computer Simulation | 1 | 2016 | 6188 | 0.010 |
Why?
|
Histones | 1 | 2012 | 2598 | 0.010 |
Why?
|
Interferon-gamma | 1 | 2010 | 3205 | 0.010 |
Why?
|
Rats, Wistar | 1 | 2004 | 1892 | 0.010 |
Why?
|
Proteomics | 1 | 2014 | 3639 | 0.010 |
Why?
|
Transplantation, Heterologous | 1 | 2008 | 2378 | 0.010 |
Why?
|
Breast Neoplasms | 1 | 2007 | 20827 | 0.010 |
Why?
|
Organ Size | 1 | 2004 | 2241 | 0.010 |
Why?
|
Cloning, Molecular | 1 | 2004 | 4320 | 0.010 |
Why?
|
Genetic Engineering | 1 | 2004 | 950 | 0.010 |
Why?
|
Neoplasm Metastasis | 1 | 2008 | 4848 | 0.010 |
Why?
|
Nerve Tissue Proteins | 1 | 2010 | 4463 | 0.010 |
Why?
|
Time Factors | 2 | 2010 | 40038 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2013 | 9440 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2010 | 14563 | 0.010 |
Why?
|
Testosterone | 1 | 2004 | 2297 | 0.010 |
Why?
|
Macrophages | 1 | 2009 | 5651 | 0.010 |
Why?
|
Base Sequence | 1 | 2004 | 12798 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2004 | 13809 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2004 | 18107 | 0.010 |
Why?
|
Immunotherapy | 1 | 2004 | 4437 | 0.010 |
Why?
|
Rats | 1 | 2004 | 24250 | 0.000 |
Why?
|